nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Prednisone—chronic obstructive pulmonary disease	0.188	0.508	CpDpCtD
Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.186	0.542	CbGaD
Cyclobenzaprine—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.182	0.492	CpDpCtD
Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.157	0.458	CbGaD
Cyclobenzaprine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0285	0.15	CbGbCtD
Cyclobenzaprine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0276	0.145	CbGbCtD
Cyclobenzaprine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0276	0.145	CbGbCtD
Cyclobenzaprine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0246	0.129	CbGbCtD
Cyclobenzaprine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0231	0.122	CbGbCtD
Cyclobenzaprine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0156	0.0821	CbGbCtD
Cyclobenzaprine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0149	0.0783	CbGbCtD
Cyclobenzaprine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0133	0.0698	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0078	0.041	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00737	0.0387	CbGbCtD
Cyclobenzaprine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00666	0.58	CbGeAlD
Cyclobenzaprine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00242	0.211	CbGeAlD
Cyclobenzaprine—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000716	0.0727	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000625	0.0635	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000553	0.0561	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00052	0.0453	CbGeAlD
Cyclobenzaprine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000452	0.0459	CbGpPWpGaD
Cyclobenzaprine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000407	0.0354	CbGeAlD
Cyclobenzaprine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000358	0.0312	CbGeAlD
Cyclobenzaprine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000328	0.0285	CbGeAlD
Cyclobenzaprine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000301	0.0262	CbGeAlD
Cyclobenzaprine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000276	0.024	CbGeAlD
Cyclobenzaprine—Protriptyline—SLC6A4—chronic obstructive pulmonary disease	0.00025	0.121	CrCbGaD
Cyclobenzaprine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.0233	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000228	0.0231	CbGpPWpGaD
Cyclobenzaprine—HTR2A—lung—chronic obstructive pulmonary disease	0.000216	0.0188	CbGeAlD
Cyclobenzaprine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.0197	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.0184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.0179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000176	0.0179	CbGpPWpGaD
Cyclobenzaprine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00228	CcSEcCtD
Cyclobenzaprine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00228	CcSEcCtD
Cyclobenzaprine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00228	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00228	CcSEcCtD
Cyclobenzaprine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00227	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00225	CcSEcCtD
Cyclobenzaprine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00224	CcSEcCtD
Cyclobenzaprine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00224	CcSEcCtD
Cyclobenzaprine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00224	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00222	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00222	CcSEcCtD
Cyclobenzaprine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0022	CcSEcCtD
Cyclobenzaprine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00219	CcSEcCtD
Cyclobenzaprine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00219	CcSEcCtD
Cyclobenzaprine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00219	CcSEcCtD
Cyclobenzaprine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00219	CcSEcCtD
Cyclobenzaprine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Cyclobenzaprine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Cyclobenzaprine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Cyclobenzaprine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00216	CcSEcCtD
Cyclobenzaprine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00216	CcSEcCtD
Cyclobenzaprine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00216	CcSEcCtD
Cyclobenzaprine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00216	CcSEcCtD
Cyclobenzaprine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Cyclobenzaprine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Cyclobenzaprine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Cyclobenzaprine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Cyclobenzaprine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00214	CcSEcCtD
Cyclobenzaprine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Cyclobenzaprine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Cyclobenzaprine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00211	CcSEcCtD
Cyclobenzaprine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00211	CcSEcCtD
Cyclobenzaprine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00211	CcSEcCtD
Cyclobenzaprine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00211	CcSEcCtD
Cyclobenzaprine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00209	CcSEcCtD
Cyclobenzaprine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.0154	CbGpPWpGaD
Cyclobenzaprine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00207	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00207	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00207	CcSEcCtD
Cyclobenzaprine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00207	CcSEcCtD
Cyclobenzaprine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000149	0.0151	CbGpPWpGaD
Cyclobenzaprine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00204	CcSEcCtD
Cyclobenzaprine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00204	CcSEcCtD
Cyclobenzaprine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00203	CcSEcCtD
Cyclobenzaprine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00203	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Cyclobenzaprine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Cyclobenzaprine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00202	CcSEcCtD
Cyclobenzaprine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00202	CcSEcCtD
Cyclobenzaprine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00201	CcSEcCtD
Cyclobenzaprine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.0148	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.002	CcSEcCtD
Cyclobenzaprine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00199	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00198	CcSEcCtD
Cyclobenzaprine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00196	CcSEcCtD
Cyclobenzaprine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00195	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00195	CcSEcCtD
Cyclobenzaprine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00193	CcSEcCtD
Cyclobenzaprine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00193	CcSEcCtD
Cyclobenzaprine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00192	CcSEcCtD
Cyclobenzaprine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00192	CcSEcCtD
Cyclobenzaprine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.0019	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00189	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00189	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00188	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00188	CcSEcCtD
Cyclobenzaprine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.0139	CbGpPWpGaD
Cyclobenzaprine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Cyclobenzaprine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Cyclobenzaprine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00186	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00186	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00185	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00184	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00184	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00184	CcSEcCtD
Cyclobenzaprine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00184	CcSEcCtD
Cyclobenzaprine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00184	CcSEcCtD
Cyclobenzaprine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00183	CcSEcCtD
Cyclobenzaprine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00182	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00182	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00182	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00182	CcSEcCtD
Cyclobenzaprine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.0134	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.0134	CbGpPWpGaD
Cyclobenzaprine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00181	CcSEcCtD
Cyclobenzaprine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000131	0.0018	CcSEcCtD
Cyclobenzaprine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.0018	CcSEcCtD
Cyclobenzaprine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00179	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Cyclobenzaprine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Cyclobenzaprine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Cyclobenzaprine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00177	CcSEcCtD
Cyclobenzaprine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00177	CcSEcCtD
Cyclobenzaprine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00176	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00175	CcSEcCtD
Cyclobenzaprine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00175	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00174	CcSEcCtD
Cyclobenzaprine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Cyclobenzaprine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.00173	CcSEcCtD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000125	0.0127	CbGpPWpGaD
Cyclobenzaprine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Cyclobenzaprine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Cyclobenzaprine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000124	0.00171	CcSEcCtD
Cyclobenzaprine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000124	0.00171	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000124	0.0017	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.0017	CcSEcCtD
Cyclobenzaprine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.0017	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.0017	CcSEcCtD
Cyclobenzaprine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.00169	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00169	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00169	CcSEcCtD
Cyclobenzaprine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00168	CcSEcCtD
Cyclobenzaprine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00167	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00166	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00165	CcSEcCtD
Cyclobenzaprine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Cyclobenzaprine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Cyclobenzaprine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.012	CbGpPWpGaD
Cyclobenzaprine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.00163	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00162	CcSEcCtD
Cyclobenzaprine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Cyclobenzaprine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Cyclobenzaprine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Cyclobenzaprine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Cyclobenzaprine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Cyclobenzaprine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Cyclobenzaprine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00158	CcSEcCtD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.0114	CbGpPWpGaD
Cyclobenzaprine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00155	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00154	CcSEcCtD
Cyclobenzaprine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.0113	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00152	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00152	CcSEcCtD
Cyclobenzaprine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00152	CcSEcCtD
Cyclobenzaprine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.0112	CbGpPWpGaD
Cyclobenzaprine—Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.000109	0.0527	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00149	CcSEcCtD
Cyclobenzaprine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.0109	CbGpPWpGaD
Cyclobenzaprine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00148	CcSEcCtD
Cyclobenzaprine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00148	CcSEcCtD
Cyclobenzaprine—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000107	0.0109	CbGpPWpGaD
Cyclobenzaprine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00146	CcSEcCtD
Cyclobenzaprine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00146	CcSEcCtD
Cyclobenzaprine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.0108	CbGpPWpGaD
Cyclobenzaprine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.0513	CrCbGaD
Cyclobenzaprine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00145	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000105	0.0107	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00144	CcSEcCtD
Cyclobenzaprine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00143	CcSEcCtD
Cyclobenzaprine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.0105	CbGpPWpGaD
Cyclobenzaprine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00141	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00141	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00141	CcSEcCtD
Cyclobenzaprine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.0014	CcSEcCtD
Cyclobenzaprine—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.0103	CbGpPWpGaD
Cyclobenzaprine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00138	CcSEcCtD
Cyclobenzaprine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.00138	CcSEcCtD
Cyclobenzaprine—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.92e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.92e-05	0.00137	CcSEcCtD
Cyclobenzaprine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	9.91e-05	0.0101	CbGpPWpGaD
Cyclobenzaprine—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.72e-05	0.00134	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.69e-05	0.00134	CcSEcCtD
Cyclobenzaprine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	9.57e-05	0.0464	CrCbGaD
Cyclobenzaprine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.00132	CcSEcCtD
Cyclobenzaprine—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.54e-05	0.00131	CcSEcCtD
Cyclobenzaprine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.54e-05	0.00131	CcSEcCtD
Cyclobenzaprine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	9.53e-05	0.00968	CbGpPWpGaD
Cyclobenzaprine—Rash—Formoterol—chronic obstructive pulmonary disease	9.46e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Rash—Arformoterol—chronic obstructive pulmonary disease	9.46e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.45e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.45e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.45e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Headache—Arformoterol—chronic obstructive pulmonary disease	9.4e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Headache—Formoterol—chronic obstructive pulmonary disease	9.4e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.37e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.34e-05	0.00129	CcSEcCtD
Cyclobenzaprine—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	9.33e-05	0.00947	CbGpPWpGaD
Cyclobenzaprine—Rash—Montelukast—chronic obstructive pulmonary disease	9.26e-05	0.00128	CcSEcCtD
Cyclobenzaprine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.26e-05	0.00128	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.24e-05	0.00127	CcSEcCtD
Cyclobenzaprine—Headache—Montelukast—chronic obstructive pulmonary disease	9.2e-05	0.00127	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.00126	CcSEcCtD
Cyclobenzaprine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.1e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	9.01e-05	0.0437	CrCbGaD
Cyclobenzaprine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.01e-05	0.00124	CcSEcCtD
Cyclobenzaprine—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.98e-05	0.00124	CcSEcCtD
Cyclobenzaprine—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.00911	CbGpPWpGaD
Cyclobenzaprine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Rash—Salbutamol—chronic obstructive pulmonary disease	8.93e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisolone—chronic obstructive pulmonary disease	8.93e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.92e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Nausea—Formoterol—chronic obstructive pulmonary disease	8.91e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.91e-05	0.00123	CcSEcCtD
Cyclobenzaprine—Headache—Salbutamol—chronic obstructive pulmonary disease	8.87e-05	0.00122	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.75e-05	0.00121	CcSEcCtD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	8.73e-05	0.00887	CbGpPWpGaD
Cyclobenzaprine—Nausea—Montelukast—chronic obstructive pulmonary disease	8.73e-05	0.0012	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	8.72e-05	0.0423	CrCbGaD
Cyclobenzaprine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.62e-05	0.00119	CcSEcCtD
Cyclobenzaprine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	8.61e-05	0.00874	CbGpPWpGaD
Cyclobenzaprine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.00118	CcSEcCtD
Cyclobenzaprine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	8.59e-05	0.0416	CrCbGaD
Cyclobenzaprine—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.41e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.00115	CcSEcCtD
Cyclobenzaprine—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.00114	CcSEcCtD
Cyclobenzaprine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	8.26e-05	0.00839	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.18e-05	0.00831	CbGpPWpGaD
Cyclobenzaprine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	8.14e-05	0.0395	CrCbGaD
Cyclobenzaprine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.12e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.12e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	8.06e-05	0.0391	CrCbGaD
Cyclobenzaprine—Shock—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.0011	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.93e-05	0.00109	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.85e-05	0.00108	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	7.85e-05	0.038	CrCbGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	7.84e-05	0.00797	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.83e-05	0.00796	CbGpPWpGaD
Cyclobenzaprine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	7.82e-05	0.0379	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	7.5e-05	0.0363	CrCbGaD
Cyclobenzaprine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.00102	CcSEcCtD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	7.39e-05	0.00751	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	7.36e-05	0.0357	CrCbGaD
Cyclobenzaprine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.35e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.00101	CcSEcCtD
Cyclobenzaprine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	7.2e-05	0.00731	CbGpPWpGaD
Cyclobenzaprine—Promazine—CYP1A2—chronic obstructive pulmonary disease	6.95e-05	0.0337	CrCbGaD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.00704	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	6.93e-05	0.0336	CrCbGaD
Cyclobenzaprine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.92e-05	0.00703	CbGpPWpGaD
Cyclobenzaprine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000939	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.71e-05	0.000925	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.69e-05	0.000922	CcSEcCtD
Cyclobenzaprine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	6.69e-05	0.0324	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—chronic obstructive pulmonary disease	6.67e-05	0.0323	CrCbGaD
Cyclobenzaprine—Agitation—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000916	CcSEcCtD
Cyclobenzaprine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	6.64e-05	0.0322	CrCbGaD
Cyclobenzaprine—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000911	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR2A—chronic obstructive pulmonary disease	6.6e-05	0.032	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	6.6e-05	0.0067	CbGpPWpGaD
Cyclobenzaprine—Malaise—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000899	CcSEcCtD
Cyclobenzaprine—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000895	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000894	CcSEcCtD
Cyclobenzaprine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	6.48e-05	0.00658	CbGpPWpGaD
Cyclobenzaprine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.45e-05	0.000889	CcSEcCtD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.44e-05	0.00654	CbGpPWpGaD
Cyclobenzaprine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000876	CcSEcCtD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.29e-05	0.00639	CbGpPWpGaD
Cyclobenzaprine—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000863	CcSEcCtD
Cyclobenzaprine—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.00086	CcSEcCtD
Cyclobenzaprine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.21e-05	0.00631	CbGpPWpGaD
Cyclobenzaprine—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000848	CcSEcCtD
Cyclobenzaprine—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000845	CcSEcCtD
Cyclobenzaprine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	6.09e-05	0.0295	CrCbGaD
Cyclobenzaprine—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000838	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	6.06e-05	0.00615	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	6.05e-05	0.0293	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.000825	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000813	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000813	CcSEcCtD
Cyclobenzaprine—Promazine—HTR2A—chronic obstructive pulmonary disease	5.87e-05	0.0284	CrCbGaD
Cyclobenzaprine—Shock—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.0008	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000794	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000786	CcSEcCtD
Cyclobenzaprine—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.000775	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	5.46e-05	0.00555	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.45e-05	0.00554	CbGpPWpGaD
Cyclobenzaprine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000741	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.37e-05	0.00074	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000736	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.00073	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000716	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR2A—chronic obstructive pulmonary disease	5.14e-05	0.0249	CrCbGaD
Cyclobenzaprine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.13e-05	0.000707	CcSEcCtD
Cyclobenzaprine—Rash—Prednisolone—chronic obstructive pulmonary disease	5.12e-05	0.000706	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.12e-05	0.000705	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	5.11e-05	0.0247	CrCbGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.1e-05	0.00518	CbGpPWpGaD
Cyclobenzaprine—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000701	CcSEcCtD
Cyclobenzaprine—Headache—Prednisolone—chronic obstructive pulmonary disease	5.09e-05	0.000701	CcSEcCtD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5.09e-05	0.00517	CbGpPWpGaD
Cyclobenzaprine—Constipation—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000695	CcSEcCtD
Cyclobenzaprine—Nortriptyline—ALB—chronic obstructive pulmonary disease	5.04e-05	0.0244	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.00067	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000665	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.83e-05	0.000665	CcSEcCtD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00487	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00487	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00487	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	4.72e-05	0.0048	CbGpPWpGaD
Cyclobenzaprine—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000646	CcSEcCtD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	4.67e-05	0.00474	CbGpPWpGaD
Cyclobenzaprine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000643	CcSEcCtD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.00464	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.57e-05	0.00464	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.51e-05	0.00458	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.00455	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000599	CcSEcCtD
Cyclobenzaprine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000584	CcSEcCtD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.21e-05	0.00427	CbGpPWpGaD
Cyclobenzaprine—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000575	CcSEcCtD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.11e-05	0.00418	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.06e-05	0.00412	CbGpPWpGaD
Cyclobenzaprine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000556	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.92e-05	0.00398	CbGpPWpGaD
Cyclobenzaprine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000538	CcSEcCtD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.00393	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.00388	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	3.79e-05	0.00385	CbGpPWpGaD
Cyclobenzaprine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.75e-05	0.000517	CcSEcCtD
Cyclobenzaprine—Rash—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.000513	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.000512	CcSEcCtD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.00377	CbGpPWpGaD
Cyclobenzaprine—Headache—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.00051	CcSEcCtD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.00376	CbGpPWpGaD
Cyclobenzaprine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000483	CcSEcCtD
Cyclobenzaprine—Amitriptyline—ALB—chronic obstructive pulmonary disease	3.49e-05	0.0169	CrCbGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.34e-05	0.00339	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	3.31e-05	0.00337	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.27e-05	0.00332	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.26e-05	0.00331	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.22e-05	0.00327	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.14e-05	0.00319	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.01e-05	0.00306	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.99e-05	0.00304	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.98e-05	0.00303	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	2.96e-05	0.00301	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.95e-05	0.003	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.87e-05	0.00291	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.76e-05	0.00281	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.73e-05	0.00277	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.71e-05	0.00275	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.00271	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	2.65e-05	0.00269	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.46e-05	0.0025	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.44e-05	0.00248	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.00246	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.26e-05	0.0023	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.00228	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.00226	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.2e-05	0.00223	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.13e-05	0.00217	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.11e-05	0.00214	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.09e-05	0.00212	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.00211	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.07e-05	0.0021	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.06e-05	0.00209	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.05e-05	0.00208	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.00205	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.00205	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.99e-05	0.00202	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.002	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.00197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.94e-05	0.00197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.92e-05	0.00195	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.92e-05	0.00195	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.00194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.9e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.89e-05	0.00192	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.87e-05	0.0019	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.0018	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.00179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.00177	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.74e-05	0.00176	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.69e-05	0.00171	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.68e-05	0.00171	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.67e-05	0.0017	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.00169	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.00167	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.58e-05	0.00161	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.53e-05	0.00155	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.48e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.46e-05	0.00148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.44e-05	0.00146	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.34e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.34e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.00129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.00121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.00119	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.16e-05	0.00118	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.12e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.06e-05	0.00107	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.05e-05	0.00107	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.04e-05	0.00105	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.02e-05	0.00104	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.6e-06	0.000975	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.57e-06	0.000972	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.49e-06	0.000964	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.45e-06	0.00096	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.04e-06	0.000918	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.04e-06	0.000918	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9e-06	0.000914	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.89e-06	0.000903	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.65e-06	0.000878	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.58e-06	0.000871	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.04e-06	0.000817	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.86e-06	0.000697	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.67e-06	0.000678	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.61e-06	0.000671	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.4e-06	0.000651	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.2e-06	0.00063	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.15e-06	0.000624	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.67e-06	0.000576	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.58e-06	0.000566	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.51e-06	0.00056	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.11e-06	0.000519	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.07e-06	0.000515	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.03e-06	0.000511	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.72e-06	0.00048	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.67e-06	0.000474	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.64e-06	0.000471	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.63e-06	0.000471	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.61e-06	0.000468	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.35e-06	0.000442	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.26e-06	0.000433	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.12e-06	0.000419	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.86e-06	0.000393	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.81e-06	0.000387	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.65e-06	0.00037	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.6e-06	0.000366	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.55e-06	0.000361	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.39e-06	0.000344	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.37e-06	0.000342	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.29e-06	0.000334	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.27e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.23e-06	0.000329	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.23e-06	0.000328	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.09e-06	0.000314	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.03e-06	0.000308	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.01e-06	0.000306	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.85e-06	0.00029	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.74e-06	0.000278	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.6e-06	0.000265	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.53e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.49e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.48e-06	0.000252	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.32e-06	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.29e-06	0.000232	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.22e-06	0.000226	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-06	0.000224	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.19e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.04e-06	0.000207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2e-06	0.000203	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.94e-06	0.000197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.85e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.68e-06	0.000171	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.54e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.5e-06	0.000152	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-06	0.000145	CbGpPWpGaD
